Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

8.50
Delayed Data
As of May 22
 +0.07 / +0.83%
Today’s Change
5.01
Today|||52-Week Range
9.24
+13.33%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Imprimis Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 13.00 and a low estimate of 12.00. The median estimate represents a +47.06% increase from the last price of 8.50.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Imprimis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.28
Sales
$1.6M
Reporting Date
May 13

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.67%
 
 
 
 
 
 
Growthannually 8.56%
 
 
 
 

Sales

Growthquarterly 184.16%
 
 
 
 
 
Growthannually 715.64%
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account